Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04892680 · ClinicalTrials.gov registry record · NA
Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes
A NA study, sponsored by Omada Health.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04892680: Clinical Trial NA study, sponsored by Omada Health.
NCT04892680 is a NA study that was terminated before completion, run by Omada Health. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04892680, a NA study, was terminated before completion, sponsored by Omada Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate a digital chronic disease self-management program designed to provide virtual support and guidance for patients with type 2 diabetes.
Primary Outcome
Non-fasting venous blood sample
Interventions
- BEHAVIORAL Online Diabetes Self-Management Education and Support (DSMES) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-03-04 |
| Est. Completion | 2021-08-02 |
| Phase | NA |
Why NCT04892680 stopped before completion
NCT04892680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Online Diabetes Self-Management Education and Support (DSMES) Program is the first listed.
NCT04892680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04892680 about?
NCT04892680 is a clinical study titled "Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes". The goal of this study is to evaluate a digital chronic disease self-management program designed to provide virtual support and guidance for patients with type 2 diabetes.
What is the current status of trial NCT04892680?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2021-03-04. Estimated completion is 2021-08-02.
What interventions are being tested in trial NCT04892680?
The interventions under investigation include: Online Diabetes Self-Management Education and Support (DSMES) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04892680?
This trial is sponsored by Omada Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04892680's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI